Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1990 May;64(5):1927–1933. doi: 10.1128/jvi.64.5.1927-1933.1990

Neuroattenuated bunyavirus variant: derivation, characterization, and revertant clones.

M J Endres 1, A Valsamakis 1, F Gonzalez-Scarano 1, N Nathanson 1
PMCID: PMC249346  PMID: 2182907

Abstract

A neuroattenuated variant bunyavirus, designated RFC/25B.5 (B.5), was selected by serial passage of a reassortant clone (RFC virus) of a California serogroup virus in BHK-21 cells, followed by plaque purification of that passaged stock. Based on its virulence index (ratio of PFU/50% lethal dose), clone B5 was over 40,000-fold less virulent than its unpassaged RFC parent after intracerebral (i.c.) inoculation into adult mice. Clone B.5 also exhibited markedly reduced neuroinvasiveness after subcutaneous injection into neonatal mice, although it retained its ability to replicate and kill suckling mice after i.c. injection. A murine neuroblastoma line (NA cells) can be used as an in vitro surrogate for the adult mouse brain, since clone B.5 replicated to at least 1,000-fold-lower titers in NA cells than did several neurovirulent California serogroup viruses. Clone B.5 replicated in BHK-21 cells at 37 degrees C to titers similar to those achieved by other California serogroup viruses but was temperature sensitive (ts) since its replication was markedly restricted at 38.9 degrees C. Ten ts revertant clones of B.5 virus were selected at 38.9 degrees C, and all of them lost their ts phenotype and regained the ability to replicate to high titer in NA cells and to kill adult mice after i.c. injection. Clone B.5 is the first described California serogroup virus which is truly attenuated after i.c. inoculation, and its availability will permit genetic analysis of bunyavirus neurovirulence.

Full text

PDF
1927

Images in this article

1931Image
on p.1931

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baric R. S., Trent D. W., Johnston R. E. A Sindbis virus variant with a cell-determined latent period. Virology. 1981 Apr 15;110(1):237–242. doi: 10.1016/0042-6822(81)90029-5. [DOI] [PubMed] [Google Scholar]
  2. Clark H. F. Rabies viruses increase in virulence when propagated in neuroblastoma cell culture. Science. 1978 Mar 10;199(4333):1072–1075. doi: 10.1126/science.628831. [DOI] [PubMed] [Google Scholar]
  3. Dietzschold B., Wiktor T. J., Trojanowski J. Q., Macfarlan R. I., Wunner W. H., Torres-Anjel M. J., Koprowski H. Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J Virol. 1985 Oct;56(1):12–18. doi: 10.1128/jvi.56.1.12-18.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gonzalez-Scarano F., Janssen R. S., Najjar J. A., Pobjecky N., Nathanson N. An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function. J Virol. 1985 Jun;54(3):757–763. doi: 10.1128/jvi.54.3.757-763.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Grimstad P. R., Barrett C. L., Humphrey R. L., Sinsko M. J. Serologic evidence for widespread infection with La Crosse and St. Louis encephalitis viruses in the Indiana human population. Am J Epidemiol. 1984 Jun;119(6):913–930. doi: 10.1093/oxfordjournals.aje.a113814. [DOI] [PubMed] [Google Scholar]
  6. Janssen R., Gonzalez-Scarano F., Nathanson N. Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab Invest. 1984 Apr;50(4):447–455. [PubMed] [Google Scholar]
  7. Johnston R. E., Smith J. F. Selection for accelerated penetration in cell culture coselects for attenuated mutants of Venezuelan equine encephalitis virus. Virology. 1988 Feb;162(2):437–443. doi: 10.1016/0042-6822(88)90484-9. [DOI] [PubMed] [Google Scholar]
  8. Kappus K. D., Monath T. P., Kaminski R. M., Calisher C. H. Reported encephalitis associated with California serogroup virus infections in the United States, 1963-1981. Prog Clin Biol Res. 1983;123:31–41. [PubMed] [Google Scholar]
  9. McMorris F. A., Ruddle F. H. Expression of neuronal phenotypes in neuroblastoma cell hybrids. Dev Biol. 1974 Aug;39(2):226–246. doi: 10.1016/0012-1606(74)90237-1. [DOI] [PubMed] [Google Scholar]
  10. Miller B. R. A variant of La Crosse virus attenuated for Aedes triseriatus mosquitoes. Am J Trop Med Hyg. 1983 Nov;32(6):1422–1428. doi: 10.4269/ajtmh.1983.32.1422. [DOI] [PubMed] [Google Scholar]
  11. Olmsted R. A., Baric R. S., Sawyer B. A., Johnston R. E. Sindbis virus mutants selected for rapid growth in cell culture display attenuated virulence in animals. Science. 1984 Jul 27;225(4660):424–427. doi: 10.1126/science.6204381. [DOI] [PubMed] [Google Scholar]
  12. Olmsted R. A., Meyer W. J., Johnston R. E. Characterization of Sindbis virus epitopes important for penetration in cell culture and pathogenesis in animals. Virology. 1986 Jan 30;148(2):245–254. doi: 10.1016/0042-6822(86)90322-3. [DOI] [PubMed] [Google Scholar]
  13. Rozhon E. J., Gensemer P., Shope R. E., Bishop D. H. Attenuation of virulence of a bunyavirus involving an L RNA defect and isolation of LAC/SSH/LAC and LAC/SSH/SSH reassortants. Virology. 1981 May;111(1):125–138. doi: 10.1016/0042-6822(81)90659-0. [DOI] [PubMed] [Google Scholar]
  14. Shope R. E., Rozhon E. J., Bishop D. H. Role of the middle-sized bunyavirus RNA segment in mouse virulence. Virology. 1981 Oct 15;114(1):273–276. doi: 10.1016/0042-6822(81)90276-2. [DOI] [PubMed] [Google Scholar]
  15. Sundin D. R., Beaty B. J., Nathanson N., Gonzalez-Scarano F. A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus. Science. 1987 Jan 30;235(4788):591–593. doi: 10.1126/science.3810159. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES